ATE191216T1 - Analogen von acronycine, verfahren zu ihrer herstellung und sie enthaltende pharmaceutische zusammensetzungen - Google Patents
Analogen von acronycine, verfahren zu ihrer herstellung und sie enthaltende pharmaceutische zusammensetzungenInfo
- Publication number
- ATE191216T1 ATE191216T1 AT95400314T AT95400314T ATE191216T1 AT E191216 T1 ATE191216 T1 AT E191216T1 AT 95400314 T AT95400314 T AT 95400314T AT 95400314 T AT95400314 T AT 95400314T AT E191216 T1 ATE191216 T1 AT E191216T1
- Authority
- AT
- Austria
- Prior art keywords
- alkoxy
- acronycine
- analogues
- acyl
- production
- Prior art date
Links
- SMPZPKRDRQOOHT-UHFFFAOYSA-N acronycine Chemical class CN1C2=CC=CC=C2C(=O)C2=C1C(C=CC(C)(C)O1)=C1C=C2OC SMPZPKRDRQOOHT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000002252 acyl group Chemical group 0.000 abstract 4
- -1 diastereoisomers Chemical class 0.000 abstract 4
- 239000004215 Carbon black (E152) Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 229930195733 hydrocarbon Natural products 0.000 abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9401806A FR2716197B1 (fr) | 1994-02-17 | 1994-02-17 | Nouveaux analogues de l'acronycine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE191216T1 true ATE191216T1 (de) | 2000-04-15 |
Family
ID=9460176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95400314T ATE191216T1 (de) | 1994-02-17 | 1995-02-15 | Analogen von acronycine, verfahren zu ihrer herstellung und sie enthaltende pharmaceutische zusammensetzungen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5567707A (de) |
| EP (1) | EP0668281B1 (de) |
| JP (1) | JP2675271B2 (de) |
| CN (1) | CN1055926C (de) |
| AT (1) | ATE191216T1 (de) |
| AU (1) | AU680080B2 (de) |
| CA (1) | CA2142560C (de) |
| DE (1) | DE69515922T2 (de) |
| DK (1) | DK0668281T3 (de) |
| ES (1) | ES2146722T3 (de) |
| FI (1) | FI118767B (de) |
| FR (1) | FR2716197B1 (de) |
| GR (1) | GR3033003T3 (de) |
| NO (1) | NO308472B1 (de) |
| NZ (1) | NZ270509A (de) |
| PT (1) | PT668281E (de) |
| ZA (1) | ZA951334B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6130161A (en) | 1997-05-30 | 2000-10-10 | International Business Machines Corporation | Method of forming copper interconnections with enhanced electromigration resistance and reduced defect sensitivity |
| FR2772765B1 (fr) * | 1997-12-19 | 2000-03-17 | Adir | Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2856687B1 (fr) * | 2003-06-25 | 2005-09-16 | Servier Lab | Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2902792A1 (fr) * | 2006-06-21 | 2007-12-28 | Servier Lab | Nouveaux derives cinnamates de tetrahydro-7h-pyrano(2,3-c)acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624087A (en) * | 1967-07-17 | 1971-11-30 | Lilly Co Eli | Synthesis of acronycine and related compounds |
| US3621041A (en) * | 1968-07-05 | 1971-11-16 | Lilly Co Eli | Chromans |
| US3673163A (en) * | 1970-06-16 | 1972-06-27 | Lilly Co Eli | Pharmacological preparation containing an acronycine-polyvinylprrolidone coprecipitate |
| US3657249A (en) * | 1970-10-12 | 1972-04-18 | Lilly Co Eli | Synthesis of nordihydroacronycine and related compounds |
| US3715359A (en) * | 1971-07-02 | 1973-02-06 | Lilly Co Eli | Hydroxylated acronycine |
| US3943137A (en) * | 1973-07-09 | 1976-03-09 | University Of Kansas Endowment Association | Acronycine derivatives |
-
1994
- 1994-02-17 FR FR9401806A patent/FR2716197B1/fr not_active Expired - Fee Related
-
1995
- 1995-02-15 EP EP95400314A patent/EP0668281B1/de not_active Expired - Lifetime
- 1995-02-15 PT PT95400314T patent/PT668281E/pt unknown
- 1995-02-15 ES ES95400314T patent/ES2146722T3/es not_active Expired - Lifetime
- 1995-02-15 DE DE69515922T patent/DE69515922T2/de not_active Expired - Fee Related
- 1995-02-15 JP JP7026866A patent/JP2675271B2/ja not_active Expired - Fee Related
- 1995-02-15 CA CA002142560A patent/CA2142560C/fr not_active Expired - Fee Related
- 1995-02-15 DK DK95400314T patent/DK0668281T3/da active
- 1995-02-15 AT AT95400314T patent/ATE191216T1/de not_active IP Right Cessation
- 1995-02-15 FI FI950681A patent/FI118767B/fi active
- 1995-02-16 US US08/389,798 patent/US5567707A/en not_active Expired - Lifetime
- 1995-02-16 NO NO950574A patent/NO308472B1/no unknown
- 1995-02-16 NZ NZ270509A patent/NZ270509A/en not_active IP Right Cessation
- 1995-02-16 AU AU12287/95A patent/AU680080B2/en not_active Ceased
- 1995-02-17 CN CN95102005A patent/CN1055926C/zh not_active Expired - Fee Related
- 1995-02-17 ZA ZA951334A patent/ZA951334B/xx unknown
-
2000
- 2000-03-30 GR GR20000400612T patent/GR3033003T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ270509A (en) | 1996-03-26 |
| NO950574D0 (no) | 1995-02-16 |
| FR2716197A1 (fr) | 1995-08-18 |
| FR2716197B1 (fr) | 1996-04-19 |
| PT668281E (pt) | 2000-07-31 |
| ES2146722T3 (es) | 2000-08-16 |
| DE69515922T2 (de) | 2000-11-02 |
| EP0668281B1 (de) | 2000-03-29 |
| DK0668281T3 (da) | 2000-08-14 |
| NO308472B1 (no) | 2000-09-18 |
| EP0668281A1 (de) | 1995-08-23 |
| GR3033003T3 (en) | 2000-07-31 |
| AU1228795A (en) | 1995-08-24 |
| CA2142560C (fr) | 2002-04-09 |
| FI950681A0 (fi) | 1995-02-15 |
| US5567707A (en) | 1996-10-22 |
| AU680080B2 (en) | 1997-07-17 |
| NO950574L (no) | 1995-08-18 |
| JPH07252257A (ja) | 1995-10-03 |
| FI118767B (fi) | 2008-03-14 |
| FI950681L (fi) | 1995-08-18 |
| CA2142560A1 (fr) | 1995-08-18 |
| DE69515922D1 (de) | 2000-05-04 |
| JP2675271B2 (ja) | 1997-11-12 |
| ZA951334B (en) | 1995-10-23 |
| CN1055926C (zh) | 2000-08-30 |
| CN1113490A (zh) | 1995-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3437695A (en) | New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them | |
| ATE128975T1 (de) | Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente. | |
| DE3482479D1 (de) | Ultrareine hyaluronsaeure und verfahren zu deren herstellung. | |
| DE3854004D1 (de) | Verfahren zur Herstellung von N-substituiertem Amin. | |
| DE69333037D1 (de) | Verfahren zur Herstellung von Beta-Diketonen | |
| YU89691A (sh) | Postupak za dobijanje stereoselektivnih derivata fenilizoserina | |
| ATE192143T1 (de) | Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE156829T1 (de) | Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE155469T1 (de) | Verfahren zur herstellung von cephemderivaten | |
| ATE325788T1 (de) | Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung | |
| DE3486438D1 (de) | Verfahren zur Herstellung von 1-(Phenyl)-1-hydroxy-2-amino-3-fluor-propan-Derivaten | |
| ATE196904T1 (de) | Benzodioxan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| ATE191216T1 (de) | Analogen von acronycine, verfahren zu ihrer herstellung und sie enthaltende pharmaceutische zusammensetzungen | |
| ATE187720T1 (de) | Diosmetin derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| DE68912809D1 (de) | Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin. | |
| AU6359198A (en) | New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ATE231136T1 (de) | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften, verfahren zu deren herstellung und pharmazeutischen zusammenstellungen, die sie enthalten | |
| ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE215080T1 (de) | 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| DE59507361D1 (de) | Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung als Glukose-6-Phosphatase Inhibitoren | |
| AT387214B (de) | Verfahren zur herstellung neuer n-substituierter, estergruppen enthaltender acrylamide | |
| ATE205189T1 (de) | Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE216392T1 (de) | 7-oxo-2,3,7,14-tetrahydro-1h-benzo(b)pyrano(3,2 h)acridincarboxylatderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DE3682371D1 (de) | Dialkoxyketone und ein verfahren zu ihrer herstellung. | |
| DE69005333D1 (de) | Polyoxazolidine, Verfahren zu ihrer Herstellung und ihre Verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |